Cognitive Bias Modification: Exploring the effects of a computer-based cognitive bias training in oncology patients at risk for depression and anxiety symptoms -(OncoCogTrain)

Cognitive Bias Modification: Exploring the effects of a computer-based cognitive bias training in oncology patients at risk for depression and anxiety symptoms -(OncoCogTrain) - Cognitive Bias Modification in oncology patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON46229

Enrollment

120

Registered

2019-05-22

Start date

2020-01-01

Completion date

Unknown

Last updated

2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

niet-specifieke kanker cancer chemotherapy

Interventions

Randomly assigned, half of the patients will receive treatment as usual (TAU) and perform a weekly session of the active CBM training for 4 weeks. The other half of the patients will receive a contr

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Receiving current cancer treatment - Patients with a score of 8 or higher in the HADS will be considered for participation in the study (HADS; Zigmond & Snaith, 1983). This cut-off shows good sensitivity and specificity in a somatic patient population (Bjelland et al., 2002). - Signed informed consent form

Exclusion criteria

Exclusion criteria: - Impossibility to obtain a valid informed consent - Insufficient comprehension of the Dutch language - IQ estimate

Design outcomes

Primary

Measure	Time frame
The primary objective of our study is to measure changes in depressive and anxiety symptoms from pre to post CBM training.	—

Secondary

Measure	Time frame
Our secondary aim is to explore patient*s psychological- and cognitive processes, and course of oncology treatment as factors of our intervention.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)